February 28, 2017
ASIT soon to discuss with US and German regulatory on further development and marketing its grass pollen product
ASIT biotech, a Belgian clinical-stage biopharmaceutical company could soon market its gp-ASIT+ grass pollen product, as it showed positive results in Phase III clinical trial in grass pollen rhinitis.